The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism

Carlo Alfieri, Anna Regalia, Francesca Zanoni, Simone Vettoretti, Mario Cozzolino, Piergiorgio Messa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.

Original languageEnglish
Pages (from-to)37-44
JournalBlood Purification
Volume47
Issue number1-3
DOIs
Publication statusPublished - 2019

Fingerprint

Secondary Hyperparathyroidism
Chronic Renal Insufficiency
Therapeutics
Habits
Dialysis
Morbidity
Mortality

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism. / Alfieri, Carlo; Regalia, Anna; Zanoni, Francesca; Vettoretti, Simone; Cozzolino, Mario; Messa, Piergiorgio.

In: Blood Purification, Vol. 47, No. 1-3, 2019, p. 37-44.

Research output: Contribution to journalArticle

Alfieri, Carlo ; Regalia, Anna ; Zanoni, Francesca ; Vettoretti, Simone ; Cozzolino, Mario ; Messa, Piergiorgio. / The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism. In: Blood Purification. 2019 ; Vol. 47, No. 1-3. pp. 37-44.
@article{16ebe711de6143d8a196435c38f697dd,
title = "The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism",
abstract = "Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.",
author = "Carlo Alfieri and Anna Regalia and Francesca Zanoni and Simone Vettoretti and Mario Cozzolino and Piergiorgio Messa",
year = "2019",
doi = "10.1159/000492918",
language = "English",
volume = "47",
pages = "37--44",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "1-3",

}

TY - JOUR

T1 - The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism

AU - Alfieri, Carlo

AU - Regalia, Anna

AU - Zanoni, Francesca

AU - Vettoretti, Simone

AU - Cozzolino, Mario

AU - Messa, Piergiorgio

PY - 2019

Y1 - 2019

N2 - Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.

AB - Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.

UR - http://www.scopus.com/inward/record.url?scp=85053749471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053749471&partnerID=8YFLogxK

U2 - 10.1159/000492918

DO - 10.1159/000492918

M3 - Article

VL - 47

SP - 37

EP - 44

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 1-3

ER -